Skip to main content
. 2020 Nov 3;61(5):614–627. doi: 10.1002/jcph.1771

Figure 6.

Figure 6

Rate of IRRs in relation to DARA Cmax (by quartiles) after the first dose of subcutaneous or intravenous DARA monotherapy. IRR, infusion‐related reaction; DARA, daratumumab; Cmax, maximum peak concentration; AE, adverse event; Q, quartile. Note: The quartiles for Cmax after the first dose were: Q1, 8.68‐124 μg/mL; Q2, 124‐194 μg/mL; Q3, 194‐254 μg/mL; and Q4, 254‐807 μg/mL.